Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

The relationship between total IgE and specific antibody testing by Immunocap in screening allergic asthma

Fortune Alabi, Christopher Alabi, Hadaya Alkhateeb, Mukudzeishe Zibanayi, Mia Zeper, Kayla Garcia, Adebanke Oderinde
European Respiratory Journal 2020 56: 195; DOI: 10.1183/13993003.congress-2020.195
Fortune Alabi
Florida Lung Asthma and Sleep specialists, Celebration, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: falabi@floridalungdoctors.com
Christopher Alabi
Florida Lung Asthma and Sleep specialists, Celebration, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hadaya Alkhateeb
Florida Lung Asthma and Sleep specialists, Celebration, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mukudzeishe Zibanayi
Florida Lung Asthma and Sleep specialists, Celebration, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mia Zeper
Florida Lung Asthma and Sleep specialists, Celebration, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kayla Garcia
Florida Lung Asthma and Sleep specialists, Celebration, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adebanke Oderinde
Florida Lung Asthma and Sleep specialists, Celebration, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

In a bid to reduce the number of tests required to diagnose allergic asthma among adult asthmatic patients, we investigated the relationship between the value of the total serum IgE and number of positive specific antibodies on Immunocap testing in a cohort of 566 asthmatic subjects.

This study is retrospective. Total IgE level and the amount of positive antibodies to common aeroallergens on the Immunocap test of each patient were recorded from their charts. A positive Immunocap result was set at level II (an antibody titer of ≥0.56kU/L) and we found the following: 386 subjects had complete data and were analyzed. 180 subjects had no positive Immunocap test while 206 of them had at least one positive Immunocap test according to our set threshold. The mode of the number of positive Immunocap tests was 2 (12% of the analyzed subjects). Pearson correlation between number of positive Immunocap results and total IgE for each patient was significant (P<0.0001, R=0.45). Figure 1 shows the percentage of Immunocap positive patients for different total IgE thresholds between 10 to 100.

Conclusions:

  1. At a total IgE level of 10KU/L in adult population, 11.6% of the subjects still have a positive specific IgE antibody testing.

  2. A low total IgE result should not preclude checking for specific IgE level in subjects suspected to have allergic asthma.

  3. We recommend that subjects with total IgE of less than 30 KU/L may not benefit from specific antibody screening tests except when they are being considered for immunotherapy.

  • Allergy
  • Asthma - management
  • Asthma - diagnosis

Footnotes

Cite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 195.

This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2020
Previous
Back to top
Vol 56 Issue suppl 64 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The relationship between total IgE and specific antibody testing by Immunocap in screening allergic asthma
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
The relationship between total IgE and specific antibody testing by Immunocap in screening allergic asthma
Fortune Alabi, Christopher Alabi, Hadaya Alkhateeb, Mukudzeishe Zibanayi, Mia Zeper, Kayla Garcia, Adebanke Oderinde
European Respiratory Journal Sep 2020, 56 (suppl 64) 195; DOI: 10.1183/13993003.congress-2020.195

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The relationship between total IgE and specific antibody testing by Immunocap in screening allergic asthma
Fortune Alabi, Christopher Alabi, Hadaya Alkhateeb, Mukudzeishe Zibanayi, Mia Zeper, Kayla Garcia, Adebanke Oderinde
European Respiratory Journal Sep 2020, 56 (suppl 64) 195; DOI: 10.1183/13993003.congress-2020.195
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE
  • Continued long-term mepolizumab in severe eosinophilic asthma protects from asthma worsening versus stopping mepolizumab: COMET trial
  • Clinical trial: Impact of Probiotical® on asthma control and inflammation
Show more Allergy and immunology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society